These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 739398)
1. [Syntheses and anti-tumor activity of N-heterocyclic compounds having the cyclic hydrazide structure (author's transl)]. Hayashi E; Higashino T; Oishi E; Iijima C; Yamagishi M; Ota C; Miwa Y; Nakajima A; Iwata S; Ohmine M; Tsuda S; Ohhira Y; Hoshi A; Kuretani K Yakugaku Zasshi; 1978 Nov; 98(11):1560-5. PubMed ID: 739398 [No Abstract] [Full Text] [Related]
2. Cancerostatics. Part V. Synthesis of some acyl hydrazine derivatives. Balicki R; Nantka-Namirski P Acta Pol Pharm; 1988; 45(1):1-7. PubMed ID: 3138893 [No Abstract] [Full Text] [Related]
3. Antitumor activity of some acylhydrazines. Rutner H; Lewin N; Woodbury EC; McBride RJ; Rao KV Cancer Chemother Rep; 1974; 58(6):803-10. PubMed ID: 4447923 [No Abstract] [Full Text] [Related]
4. [Studies on the syntheses of analgesics. LIII. Synthesis of 3-(4-substituted phenyl)-2-oxobutanamide derivatives (studies on the syntheses of heterocyclic compounds. DCCCXLV) (author's transl)]. Kametani T; Kigasawa K; Hiiragi M; Ishimaru H; Nakamura T; Shirayama K Yakugaku Zasshi; 1980 Jun; 100(6):649-56. PubMed ID: 6970262 [No Abstract] [Full Text] [Related]
5. [Screening test of tumor potency of chemicals against sarcoma 180 ascites tumor cells (author's transl)]. Nagai T; Morita N; Yunoki K; Tomomatsu H; Shiwaku Y; Shingami T; Kihara K; Hashimoto S Igaku Kenkyu; 1978 Apr; 48(3):256-66. PubMed ID: 716808 [No Abstract] [Full Text] [Related]
6. [Antitumor immunity in mice bearing sarcoma 180 after treatment with the combination of diazoacetylglycine hydrazide and 5-fluorouracil]. Baldini L; Brambilla G; Cavanna M; Parodi S Boll Soc Ital Biol Sper; 1968 Mar; 44(5):443-6. PubMed ID: 5674632 [No Abstract] [Full Text] [Related]
7. Synthesis and evaluation of 2-substituted 1-methyl-1-(4-tolylsulfonyl)hydrazines as antineoplastic agents. Hrubiec RT; Shyam K; Cosby LA; Furubayashi R; Sartorelli AC J Med Chem; 1986 Jul; 29(7):1299-301. PubMed ID: 3806580 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of 1,2,2-tris(sulfonyl)hydrazines as antineoplastic and trypanocidal agents. Shyam K; Penketh PG; Divo AA; Loomis RH; Patton CL; Sartorelli AC J Med Chem; 1990 Aug; 33(8):2259-64. PubMed ID: 2374151 [TBL] [Abstract][Full Text] [Related]
9. [Studies on antitumor effects of guanidino compounds and complexone derivatives (author's transl)]. Nagai T Igaku Kenkyu; 1978 Jun; 48(5):333-467. PubMed ID: 102101 [No Abstract] [Full Text] [Related]
10. [Tumour inhibitory N-(bis--(2-chlorethyl)-aminomethyl)-urethanes (author's transl)]. Schïnenberger H; Schmidt F; Bindl L Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1975 Nov; 84(3):277-40. PubMed ID: 128219 [TBL] [Abstract][Full Text] [Related]
11. [Studies on heterocyclic compounds. III. Synthesis of 2-(2,6-dichlorobenzylidenehydrazino)-1,4,5,6-tetrahydropyrimidine hydrochloride and its related compounds (author's transl)]. Tsujikawa T; Hayashi M; Masuda K Yakugaku Zasshi; 1975 Nov; 95(11):1271-82. PubMed ID: 1240925 [No Abstract] [Full Text] [Related]
12. [Studies on the syntheses of heterocyclic compounds. DCCLXXVI. Cyclization reaction of N-substituted mandelohydrazide with formaldehyde (author's transl)]. Kametani T; Kigasawa K; Hiiragi M; Wagatsuma N; Kohagizawa T; Inoue H Yakugaku Zasshi; 1979 Feb; 99(2):135-40. PubMed ID: 571464 [No Abstract] [Full Text] [Related]
13. Synthesis and screening of cyclic benzylhydrazine congeners as antidepressants. Taha AM; Omar NM; Bayomi SM; Ammar EM; Afifi A J Pharm Sci; 1974 Mar; 63(3):395-8. PubMed ID: 4820369 [No Abstract] [Full Text] [Related]
14. [Syntheses of the amides derived from heterocyclic acids and heterocyclic amines and their antitumor activities (author's transl)]. Takatori K; Imai K; Nakano S; Hasegawa T; Asano S Yakugaku Zasshi; 1976 Apr; 96(4):471-4. PubMed ID: 945828 [No Abstract] [Full Text] [Related]
15. Novel human neuropeptide Y Y5 receptor antagonists for the treatment of obesity. Synthesis and biological evaluation of pyridine hydrazide derivatives. Galiano S; Erviti O; Pérez S; Moreno A; Juanenea L; Aldana I; Monge A Arzneimittelforschung; 2005; 55(2):81-5. PubMed ID: 15787274 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and preliminary in vitro evaluation of antimycobacterial activity of new pyrrolo[1,2-a] quinoxaline-carboxylic acid hydrazide derivatives. Guillon J; Reynolds RC; Leger JM; Guie MA; Massip S; Dallemagne P; Jarry C J Enzyme Inhib Med Chem; 2004 Dec; 19(6):489-95. PubMed ID: 15662953 [TBL] [Abstract][Full Text] [Related]
17. Discovery process and characterization of novel carbohydrazide derivatives as potent and selective GHSR1a antagonists. Sabbatini FM; Di Fabio R; Corsi M; Cavanni P; Bromidge SM; St-Denis Y; D'Adamo L; Contini S; Rinaldi M; Guery S; Savoia C; Mundi C; Perini B; Carpenter AJ; Dal Forno G; Faggioni F; Tessari M; Pavone F; Di Francesco C; Buson A; Mattioli M; Perdona' E; Melotto S ChemMedChem; 2010 Sep; 5(9):1450-5. PubMed ID: 20593439 [No Abstract] [Full Text] [Related]
18. [Studies on pyrazolo [3,4-d] pyrimidine derivatives. VIII. On syntheses and anti-tumor activity of 4-amino-1-(o-, m- or p-nitrophenyl) -1H-pyrazolo[3,4-d] pyrimidines and their derivatives (author's transl)]. Hayashi E; Higashino T; Suzuki S; Kato T; Kohno M; Shinoda H; Mizuno D Yakugaku Zasshi; 1977 Dec; 97(12):1328-33. PubMed ID: 609046 [No Abstract] [Full Text] [Related]